CBER Should Retain Jurisdiction of Assigned Device Reviews – HHS Report
Improved device review times, including speedy handling of West Nile Virus diagnostics, convinced HHS that the Center for Biologics Evaluation & Research should retain jurisdiction over blood and tissue-related devices already assigned to the center
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
